128 related articles for article (PubMed ID: 25245988)
41. DUSP16 ablation arrests the cell cycle and induces cellular senescence.
Zhang H; Zheng H; Mu W; He Z; Yang B; Ji Y; Hui L
FEBS J; 2015 Dec; 282(23):4580-94. PubMed ID: 26381291
[TBL] [Abstract][Full Text] [Related]
42. A distinct interaction mode revealed by the crystal structure of the kinase p38α with the MAPK binding domain of the phosphatase MKP5.
Zhang YY; Wu JW; Wang ZX
Sci Signal; 2011 Dec; 4(204):ra88. PubMed ID: 22375048
[TBL] [Abstract][Full Text] [Related]
43. Rhodanine derivatives as inhibitors of JSP-1.
Cutshall NS; O'Day C; Prezhdo M
Bioorg Med Chem Lett; 2005 Jul; 15(14):3374-9. PubMed ID: 15961311
[TBL] [Abstract][Full Text] [Related]
44. DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death.
Low HB; Wong ZL; Wu B; Kong LR; Png CW; Cho YL; Li CW; Xiao F; Xin X; Yang H; Loo JM; Lee FYX; Tan IBH; DasGupta R; Shen HM; Schwarz H; Gascoigne NRJ; Goh BC; Xu X; Zhang Y
Nat Commun; 2021 Apr; 12(1):2284. PubMed ID: 33863904
[TBL] [Abstract][Full Text] [Related]
45. Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening.
Ye Y; Zhang B; Mao R; Zhang C; Wang Y; Xing J; Liu YC; Luo X; Ding H; Yang Y; Zhou B; Jiang H; Chen K; Luo C; Zheng M
Org Biomol Chem; 2017 May; 15(17):3648-3661. PubMed ID: 28397890
[TBL] [Abstract][Full Text] [Related]
46. Quinoxalinylurea derivatives as a novel class of JSP-1 inhibitors.
Zhang L; Qiu B; Xiong B; Li X; Li J; Wang X; Li J; Shen J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2118-22. PubMed ID: 17303416
[TBL] [Abstract][Full Text] [Related]
47. Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase.
Lokareddy RK; Bhardwaj A; Cingolani G
Biochemistry; 2013 Feb; 52(5):938-48. PubMed ID: 23298255
[TBL] [Abstract][Full Text] [Related]
48. Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7.
Kim KH; An DR; Song J; Yoon JY; Kim HS; Yoon HJ; Im HN; Kim J; Kim DJ; Lee SJ; Kim KH; Lee HM; Kim HJ; Jo EK; Lee JY; Suh SW
Proc Natl Acad Sci U S A; 2012 May; 109(20):7729-34. PubMed ID: 22547814
[TBL] [Abstract][Full Text] [Related]
49. Structural analysis of human dual-specificity phosphatase 22 complexed with a phosphotyrosine-like substrate.
Lountos GT; Cherry S; Tropea JE; Waugh DS
Acta Crystallogr F Struct Biol Commun; 2015 Feb; 71(Pt 2):199-205. PubMed ID: 25664796
[TBL] [Abstract][Full Text] [Related]
50. Design and virtual screening towards synthesis of novel substituted thiosemicarbozones as ribonuleotide reductase (RNR) inhibitors with improved cellular trafficking and anticancer activity.
Gokhale N; Jain S; Yadav M
Curr Top Med Chem; 2015; 15(1):37-42. PubMed ID: 25579572
[TBL] [Abstract][Full Text] [Related]
51. Discovery of Entamoeba histolytica hexokinase 1 inhibitors through homology modeling and virtual screening.
Saucedo-Mendiola ML; Salas-Pacheco JM; Nájera H; Rojo-Domínguez A; Yépez-Mulia L; Avitia-Domínguez C; Téllez-Valencia A
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):325-32. PubMed ID: 23534932
[TBL] [Abstract][Full Text] [Related]
52. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
Petersen GO; Saxena S; Renuka J; Soni V; Yogeeswari P; Santos DS; Bizarro CV; Sriram D
J Mol Graph Model; 2015 Jul; 60():124-31. PubMed ID: 26043661
[TBL] [Abstract][Full Text] [Related]
53. Discovery of Cdc25A Lead Inhibitors with a Novel Chemotype by Virtual Screening: Application of Pharmacophore Modeling Based on a Training Set with a Limited Number of Unique Components.
Ge YS; Han QQ; Duan W; Zhang JQ; Chen K; Wan JJ; Liu Y; Liu D
ChemMedChem; 2017 Mar; 12(6):438-447. PubMed ID: 28198152
[TBL] [Abstract][Full Text] [Related]
54. MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation.
Hoornaert I; Marynen P; Goris J; Sciot R; Baens M
Oncogene; 2003 Oct; 22(49):7728-36. PubMed ID: 14586399
[TBL] [Abstract][Full Text] [Related]
55. Dual specificity phosphatase16 is a negative regulator of c-Jun NH2-terminal kinase activity in T cells.
Kumabe S; Itsumi M; Yamada H; Yajima T; Matsuguchi T; Yoshikai Y
Microbiol Immunol; 2010 Feb; 54(2):105-11. PubMed ID: 20377744
[TBL] [Abstract][Full Text] [Related]
56. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
[TBL] [Abstract][Full Text] [Related]
57. Preparation of 6-substituted quinoxaline JSP-1 inhibitors by microwave accelerated nucleophilic substitution.
Zhang L; Qiu B; Li X; Wang X; Li J; Zhang Y; Liu J; Li J; Shen J
Molecules; 2006 Dec; 11(12):988-99. PubMed ID: 18007403
[TBL] [Abstract][Full Text] [Related]
58. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
Hou X; Li K; Yu X; Sun JP; Fang H
J Chem Inf Model; 2015 Sep; 55(9):1973-83. PubMed ID: 26360643
[TBL] [Abstract][Full Text] [Related]
59. Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screening.
Ghattas MA; Atatreh N; Bichenkova EV; Bryce RA
J Mol Graph Model; 2014 Jul; 52():114-23. PubMed ID: 25038507
[TBL] [Abstract][Full Text] [Related]
60. Discovery of MEK/PI3K dual inhibitor via structure-based virtual screening.
Park H; Lee S; Hong S
Bioorg Med Chem Lett; 2012 Aug; 22(15):4946-50. PubMed ID: 22771009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
